Welltech Ventures

Antidote Health operates an AI-based health platform focused on improving access to healthcare and enhancing the patient experience. Its telemedicine application streamlines patient screening and supports doctors in their decision-making, alleviating administrative burdens typically associated with medical practice. This approach not only aims to provide affordable healthcare but also addresses social health aspects, fostering a positive ripple effect that extends from doctors to patients and their families, ultimately benefiting entire communities. By integrating technology and healthcare, Antidote Health seeks to elevate the quality of care while making it more accessible and efficient for all stakeholders involved.

MDI Health is a prominent provider of medication management solutions that utilizes artificial intelligence to enhance and personalize medication therapy. The company's advanced platform analyzes extensive pharmacological and medical data to identify patients at high risk for drug-related issues. MDI Health generates evidence-based recommendations aimed at mitigating these risks, which is particularly beneficial for payors and value-based providers. By employing its technology, these entities can prevent medication-related problems, optimize deprescribing efforts, and significantly reduce overall healthcare costs, achieving substantial savings per patient per year. MDI Health's decision support system, powered by big data and machine learning algorithms, continually refines its predictions and recommendations, allowing healthcare professionals to detect potential medication-related complications early in the treatment process.

Quris Technologies is an artificial intelligence innovator focused on transforming the pharmaceutical industry. The company has developed a bio clinical-prediction platform that utilizes AI to enhance the safety and efficacy of new drugs. This fully automated and self-trained platform predicts clinical outcomes more quickly and cost-effectively, while significantly reducing the need for animal testing through the use of patients-on-a-chip technology. By enabling pharmaceutical companies to mitigate the risks and expenses associated with failed clinical trials, Quris aims to improve the drug development process and promote more reliable testing methods.

Behavidence is a technology company that focuses on diagnosing and monitoring mental health conditions through the use of artificial intelligence. By analyzing subtle changes in phone usage patterns, Behavidence provides AI models for conditions such as Depression, Anxiety, Stress, ADHD, and PPD. The platform is designed for adoption by health organizations, technology firms, and government entities worldwide. Its applications extend beyond screening to include remote monitoring, detection of comorbidities, and assessment of therapeutic efficacy and potential relapses. Behavidence emphasizes user privacy, ensuring minimal burden on respondents while delivering real-time feedback. Through digital phenotyping and machine learning algorithms, the company offers high-accuracy tools to enhance the quality of care for users, caregivers, and clinical therapists.

Quris Technologies is an artificial intelligence innovator focused on transforming the pharmaceutical industry. The company has developed a bio clinical-prediction platform that utilizes AI to enhance the safety and efficacy of new drugs. This fully automated and self-trained platform predicts clinical outcomes more quickly and cost-effectively, while significantly reducing the need for animal testing through the use of patients-on-a-chip technology. By enabling pharmaceutical companies to mitigate the risks and expenses associated with failed clinical trials, Quris aims to improve the drug development process and promote more reliable testing methods.

Helping Hand is a mental health platform based in Poland that provides personalized psychological support to individuals experiencing issues such as depression, anxiety, and stress. The platform features a comprehensive app that connects users with experienced and verified psychotherapists, offering valuable content and facilitating interactive meetings. This innovative service allows users to access a full range of mental health resources tailored to their specific needs, ensuring they receive the support necessary for their well-being.

Amkiri is a manufacturer of a unique beauty product that combines fragrance and visual elements, allowing for multi-sensory self-expression. The company has developed patented ink infused with alcohol-free, vegan, and cruelty-free perfumes that can be applied to the skin using specially designed applicators. This innovative ink not only offers a long-lasting scent but can also be easily removed with soap and water. By creating a product that merges the senses of smell and sight, Amkiri enables users to enhance their daily rituals with creativity and personal expression.

X-trodes is a technology start-up specializing in the development of innovative wearable and wireless technology for the advanced monitoring and analysis of biopotential signals. The company has created a scalable wireless electronic skin designed for precise electrophysiological monitoring. Its core technology offers objective and automated data collection with high resolution, making it suitable for clinical evaluation and treatment. This allows patients to assess the health of their brains, eyes, muscles, and hearts during both sleep and daily activities, ultimately aiming to enhance their quality of life.

Behavidence is a technology company that focuses on diagnosing and monitoring mental health conditions through the use of artificial intelligence. By analyzing subtle changes in phone usage patterns, Behavidence provides AI models for conditions such as Depression, Anxiety, Stress, ADHD, and PPD. The platform is designed for adoption by health organizations, technology firms, and government entities worldwide. Its applications extend beyond screening to include remote monitoring, detection of comorbidities, and assessment of therapeutic efficacy and potential relapses. Behavidence emphasizes user privacy, ensuring minimal burden on respondents while delivering real-time feedback. Through digital phenotyping and machine learning algorithms, the company offers high-accuracy tools to enhance the quality of care for users, caregivers, and clinical therapists.

Amai Proteins is focused on revolutionizing the food and beverage industry by developing healthy and flavorful protein ingredients, particularly as sugar substitutes. The company specializes in Sweet Designer Proteins derived from naturally occurring sweet proteins found in the equatorial region. Using Agile Integrative Computational Protein Design and precision fermentation, Amai aims to create hyper-sweet designer proteins that are not only tasty and stable but also sustainable and cost-effective. This innovative approach enables the mass production of these protein ingredients, catering to the growing demand for healthier alternatives in the food market.

Antidote Health operates an AI-based health platform focused on improving access to healthcare and enhancing the patient experience. Its telemedicine application streamlines patient screening and supports doctors in their decision-making, alleviating administrative burdens typically associated with medical practice. This approach not only aims to provide affordable healthcare but also addresses social health aspects, fostering a positive ripple effect that extends from doctors to patients and their families, ultimately benefiting entire communities. By integrating technology and healthcare, Antidote Health seeks to elevate the quality of care while making it more accessible and efficient for all stakeholders involved.

Using computer vision, Sency builds the brain of movement in order to drive people towards an active and healthy life. Founded in 2019, Sency created the See.Know.Guide (SKG) methodology. Using a mobile device camera, our unique algorithm understands movement thanks to massive data collection and expert knowledge. As a result, it provides real-time guidance and personalized plans. Sency's brain is constantly learning to serve with accurate actionable insights. Our technology is running on the Edge. All data is kept on the client’s device: no streaming to the cloud means no latency, no recording, and no chance of a breach of privacy. As a user-centric approach, Sency deploys interactive experiences on consumer devices only - no hardware required. Our first applications based on our core technology are the “Sency Health” and the “WODProof” apps. From health to fitness, Sency already helped 450,000 people worldwide to achieve their physical goals and keep continuing.

Amkiri is a manufacturer of a unique beauty product that combines fragrance and visual elements, allowing for multi-sensory self-expression. The company has developed patented ink infused with alcohol-free, vegan, and cruelty-free perfumes that can be applied to the skin using specially designed applicators. This innovative ink not only offers a long-lasting scent but can also be easily removed with soap and water. By creating a product that merges the senses of smell and sight, Amkiri enables users to enhance their daily rituals with creativity and personal expression.

Amai Proteins is focused on revolutionizing the food and beverage industry by developing healthy and flavorful protein ingredients, particularly as sugar substitutes. The company specializes in Sweet Designer Proteins derived from naturally occurring sweet proteins found in the equatorial region. Using Agile Integrative Computational Protein Design and precision fermentation, Amai aims to create hyper-sweet designer proteins that are not only tasty and stable but also sustainable and cost-effective. This innovative approach enables the mass production of these protein ingredients, catering to the growing demand for healthier alternatives in the food market.